Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

NCT07481032 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

1034

Enrollment

OTHER

Sponsor class

Conditions

Cirrhosis, Liver
Hepatocellular Carcinoma (HCC)
HEPATITIS B CHRONIC

Interventions

DRUG: Biejia-Ruangan compound
DRUG: Biejia-Ruangan compound simulant

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]
[object Object]